Biopolitics, Mythic Science, and Progressive Values
By Marcy Darnovsky,
Progress in Bioethics
| 01. 29. 2010
From The MIT Press announcement:
Progress in Bioethics: Science, Policy, and Politics
Edited by Jonathan D. Moreno and Sam Berger
Foreword by Harold Shapiro
Table of Contents and Sample Chapters
Bioethics has become increasingly politicized over the past decade. Conservative voices dominated the debate at first, but the recent resurgence of progressivism and the application of its fundamental values (social justice, critical optimism, practical problem solving) to bioethical issues have helped correct this ideological imbalance. Progress in Bioethics is the first book to debate the meaning of progressive bioethics and to offer perspectives on the topic both from bioethicists who consider themselves progressive and from bioethicists who do not. It aims to begin a dialogue and to provide a foothold for readers interested in understanding the field.
The chapter authors--leading scholars in the field--discuss the meaning of progressive bioethics, the rise of conservative bioethics, the progressive stance toward biotechnology, the interplay of progressive bioethics and religion, and progressive approaches to such specific policy issues as bioethics commissions, stem cell research, and health-care reform.
The arrival of a new administration...
Related Articles
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
After almost 20 years of publicity stunts and dubious claims, we may not have 23andMe to kick around anymore. The company has filed for Chapter 11 bankruptcy protection. The stock has collapsed to about 2% of its peak value. CEO and co-founder Anne Wojcicki has quit (though she may be baaack) and the company’s future, if any, depends on its DNA database.
Note to customers of the company: Get Out. Cybersecurity expert Adrianus Warmenhoven told the Associated Press...
By ACLU Northern California
| 03.21.2025
In a long-standing lawsuit, the ACLU, on behalf of partner organizations and an individual taxpayer, is challenging the state of California for its retention of genetic samples and profiles from people arrested but never convicted of a felony.
The complaint...
By Loren Johnston, Portland Press Herald | 03.15.2025